Stark Law and Anti-Kickback Statute: What Physicians Must Know Before Investing in Healthcare Companies

Key Takeaways

• The Stark Law is a strict-liability civil statute: if a physician refers Medicare patients for designated health services to an entity they have a financial relationship with, and no exception applies, the claims are not payable, regardless of intent.
• The Anti-Kickback Statute is a criminal, intent-based law that covers anything of value offered or received to induce referrals of federal health care program business, and it applies to everyone, not just physicians.
• An ownership or investment interest counts as a financial relationship under both laws, including interests held indirectly through a holding company, fund, or SPV.
• Physician owned hospitals face their own restrictions: Section 6001 of the Affordable Care Act grandfathered hospitals with physician ownership in place by December 31, 2010, and sharply limits their expansion.
• Many physician investments carry little exposure under either law, but risk rises quickly when the company bills federal programs or the physician is in a position to generate its business.

Physicians are some of the most natural investors in healthcare innovation, a point explored in more depth in our look at why clinical experience gives doctors an edge as healthcare investors. That same clinical role is what makes physician investing legally different from anyone else's. A physician can refer patients, order tests, prescribe drugs, and choose devices, so federal law treats a physician's financial stake in a healthcare company as something that could distort medical judgment. The two laws that do most of this work are the Stark Law and the Anti-Kickback Statute. Understanding them is a practical requirement for any physician weighing a deal through The LSM Group's healthcare, AI, and life-sciences network or anywhere else.

This guide explains what each law prohibits, how they differ, how they apply to physician owned hospitals, and how they tend to play out across the investment types physicians actually encounter, from publicly traded stocks to early-stage startups. It describes how the rules work as of October 2026. It is educational content, not legal or investment advice, and any specific arrangement should be reviewed by experienced healthcare counsel.

Why These Laws Matter Before You Invest

Most investors evaluate a deal on market size, team, and terms. Physicians have to add a fourth lens: whether owning the asset changes the legal status of their own clinical decisions. A return on capital that would be ordinary for a software engineer can become a prohibited financial relationship for a physician who sends patients to the same company.

The consequences fall on both sides. Under physician self-referral rules, the company may be unable to bill Medicare for services the physician-investor refers, which damages the investment itself. Under kickback rules, both the physician and the company can face criminal and civil exposure. In both cases, the problem usually surfaces years after the check is written, during an audit, an acquisition's due diligence, or a whistleblower case. That is why the analysis belongs before the investment, not after.

What Is the Stark Law?

The Stark Law, codified at 42 U.S.C. § 1395nn and named for former Congressman Pete Stark, is the federal physician self-referral law. In its core form, it says two things:

• The referral ban: when a physician, or someone in the physician's immediate family, holds a financial stake in or gets paid by an entity, the physician cannot send Medicare patients there for "designated health services" unless the relationship fits an exception.
• The billing ban: the entity that receives a prohibited referral cannot collect from Medicare for the resulting services.

Because the prohibition runs through the referral, the law only bites where three elements meet: a physician, a referral for designated health services, and a financial relationship with the entity furnishing them.

Designated Health Services

The statute does not cover every healthcare service. It reaches only designated health services (DHS), and for imaging and radiation therapy CMS publishes an annual code list that settles which specific services are in scope. For an investor, it helps to sort the categories by the kind of business that furnishes them:

• Diagnostics: clinical laboratory testing, plus radiology and certain other imaging.
• Therapy and treatment: physical therapy, occupational therapy, outpatient speech-language pathology, and radiation therapy.
• Equipment and supplies: durable medical equipment, prosthetics and orthotics, and parenteral and enteral nutrition products.
• Care settings and drugs: home health, outpatient prescription drugs, and both inpatient and outpatient hospital care.

This list explains why some healthcare investments raise Stark issues and others do not. A diagnostic lab, an imaging center, a physical therapy clinic, or a hospital furnishes DHS. A health-system software vendor or a clinical decision-support tool that never bills Medicare for a service typically does not.

Ownership and Investment Interests Count

The statute defines a financial relationship to include "an ownership or investment interest in the entity," which "may be through equity, debt, or other means." Compensation arrangements, such as consulting fees or medical director payments, are the other branch of the definition.

Two details matter for investors. First, the definition reaches debt as well as equity, so a convertible note or loan can count. Second, the regulations treat indirect ownership as ownership. A physician who holds an interest in a fund or special purpose vehicle that in turn owns a DHS entity can still have an ownership interest for Stark purposes. Pooling capital through a syndicate does not, by itself, remove the analysis.

Strict Liability and Penalties

Stark is a strict-liability statute. Intent is irrelevant: a referral that does not fit an exception is prohibited even if the physician acted in good faith and never thought about the money. Every element of an exception must be met, and technical failures, such as an expired written agreement, can be enough to fall outside protection.

The sanctions are financial and administrative:

• Denial of payment for services furnished under a prohibited referral, and an obligation to refund amounts already collected.
• Civil monetary penalties with a statutory base of up to $15,000 per service, adjusted annually for inflation.
• Penalties with a statutory base of up to $100,000 for each arrangement or scheme designed to circumvent the law.
• Potential exclusion from federal health care programs, and False Claims Act liability where prohibited claims are knowingly submitted.

CMS runs a Self-Referral Disclosure Protocol that lets providers self-report actual or potential Stark Law violations, which is often how problems found in an acquisition or audit are resolved.

The Ownership Exceptions Physician Investors Meet Most Often

Stark contains many exceptions, but only a handful apply to ownership and investment interests, set out in 42 CFR § 411.356:

• Publicly traded securities: investment securities that could be bought on the open market at the time of the referral, listed on a qualifying exchange, issued by a corporation with stockholder equity above $75 million at the end of its most recent fiscal year or on average over the prior three years.
• Mutual funds: shares in a regulated investment company with total assets above $75 million.
• Rural providers: entities furnishing substantially all of their DHS to residents of a rural area.
• Hospital ownership: the "whole hospital" exception, now limited to grandfathered physician owned hospitals that meet Section 6001 requirements (covered below).

There is also a general exception for in-office ancillary services, which lets physicians furnish certain DHS within their own group practice. That exception governs the practice's own services. It does not cover an ownership stake in an outside company.

What Is the Anti-Kickback Statute?

The Anti-Kickback Statute, at 42 U.S.C. § 1320a-7b(b), works from the opposite direction. Instead of listing forbidden structures, it targets the reason value changes hands. If something of value moves between two parties, whether as cash, equity, a discount, or a favor, and a purpose of that transfer is to generate business that Medicare, Medicaid, TRICARE, or another federal program will pay for, the person giving it and the person taking it can both commit a felony, provided they act knowingly and willfully.

Unlike Stark, this law is not limited to physicians, to referrals in the narrow sense, or to a list of service categories. It covers anyone on either side of the payment, and it reaches ordering, purchasing, recommending, and arranging for items or services, not only patient referrals.

Remuneration and Intent

"Remuneration" means anything of value. For investors, the key point is that an investment opportunity itself can be remuneration. Long-standing guidance from the HHS Office of Inspector General (OIG) treats the chance to earn a profit through an investment in an entity the physician generates business for as potential illegal remuneration, especially when the opportunity is offered because of that business.

The intent standard is "knowingly and willfully," but it is broader than it sounds. Courts have long applied a "one purpose" test, under which a payment can violate the statute if one purpose, not necessarily the main purpose, is to induce referrals. And since 2010, the statute itself says that a person "need not have actual knowledge of this section or specific intent to commit a violation of this section."

Penalties and the False Claims Act Link

The Bipartisan Budget Act of 2018 doubled the criminal ceiling, so each violation committed after February 9, 2018 can now carry a fine as high as $100,000, a prison term as long as 10 years, or both. On the administrative side, OIG can seek civil monetary penalties, again with a $100,000 statutory base per violation that is indexed to inflation, on top of an assessment of up to triple the remuneration, and it can exclude the physician or company from federal programs altogether.

The largest practical exposure often comes from a separate provision. Since the Affordable Care Act, the statute provides that a claim including items or services "resulting from" a violation is a false claim under the False Claims Act. That opens the door to treble damages, per-claim penalties, and whistleblower (qui tam) lawsuits, which is why kickback cases are frequently brought by insiders.

Safe Harbors for Investment Interests

Because the statute is so broad, OIG publishes regulatory safe harbors at 42 CFR § 1001.952. An arrangement that fits a safe harbor is protected. One that does not is not automatically illegal, but it is judged on its facts and intent. Two investment safe harbors matter most:

• Large entities: investments in entities with more than $50 million in undepreciated net tangible assets related to healthcare, with equity registered with the SEC and investor terms that do not depend on referrals.
• Small entities: an eight-part test that includes the two "60-40" rules. No more than 40 percent of the value of each class of investment interest may be held by investors in a position to make or influence referrals, and no more than 40 percent of the entity's gross revenue may come from business generated by investors. Terms offered to passive investors must match those offered to others, the entity may not loan funds to investors to buy their interests, and returns must be directly proportional to capital invested.

Separate safe harbors cover arrangements such as certain physician investments in ambulatory surgical centers and personal services agreements at fair market value.

Stark Law vs Anti-Kickback Statute: Key Differences

The two laws overlap, and a single arrangement can implicate both, but they work differently. A Stark Law vs Anti-Kickback Statute comparison on the dimensions that matter most to a physician-investor looks like this:

A useful way to remember the difference: Stark asks whether the structure fits an exception, while the kickback statute asks why the money moved. An arrangement can pass Stark through an exception and still raise kickback questions if the investment was offered to reward referrals, and the reverse is also possible.

Physician Owned Hospitals and the Section 6001 Restrictions

For decades, the "whole hospital" exception let physicians invest in an entire hospital rather than a department of it, on the theory that one physician's referrals would have little effect on the returns of a full-service hospital. Section 6001 of the Affordable Care Act changed that in 2010. CMS summarizes the current rules on its page covering hospitals with physician ownership.

The main restrictions on physician owned hospitals are:

• Grandfathering: only hospitals that already combined physician ownership with an active Medicare provider agreement on December 31, 2010 can still rely on the exception. A hospital opened later with physicians on the cap table has no path to it.
• Growth limits: March 23, 2010 works as a freeze date. The licensed count of beds, operating rooms, and procedure rooms on that day is the ceiling, and the combined share of the hospital owned by physicians cannot rise above its level on that day either.
• Expansion exception: CMS may approve limited expansion for a hospital that qualifies as an "applicable hospital" or a "high Medicaid facility." CMS revised this request process in its FY 2024 inpatient payment rule, effective October 1, 2023.
• Disclosure and investor-terms requirements: grandfathered hospitals must meet conditions on disclosure of physician ownership and on how investment interests are offered and financed.

The issue remains active in 2026. The FY 2027 inpatient prospective payment system rulemaking, finalized in August 2026, raised whether CMS Innovation Center authority could allow hospitals with physician ownership to participate in an Innovation Center payment model. Bills have also been introduced in the 119th Congress to repeal Section 6001 or create rural carve-outs. These are factual developments, not a forecast. For an investor, the practical point is that a hospital investment opportunity needs a clear answer on grandfathered status and capacity limits before any other diligence matters.

How the Rules Apply to Common Physician Investments

The same two statutes produce very different risk levels depending on what the company does and where the physician sits relative to it. The patterns below describe how the analysis typically runs. They are not conclusions about any specific deal.

Public Healthcare Stocks and Funds

Buying shares of a large, publicly traded healthcare company or a broad mutual fund is usually the lowest-friction path. The Stark Law exceptions for publicly traded securities and mutual funds exist precisely for this case, and the large-entity kickback safe harbor covers many large issuers. Risk can return if the physician receives shares on special terms not available to the public, or the investment comes bundled with a consulting or referral arrangement.

Early-Stage Startups That Do Not Bill Federal Programs

Many early-stage healthcare and AI companies do not furnish designated health services or bill Medicare at all, for example clinical workflow software sold to health systems or research-stage diagnostics. A passive investment in that kind of company typically sits outside physician self-referral rules, and kickback exposure is limited when the physician is not generating federal program business for it.

Two things change that picture. One is the business model maturing: a startup that begins billing Medicare, or whose product becomes reimbursable, may create exposure that did not exist at the seed stage. The other is the physician's role: a physician who also becomes a customer, prescriber, or user of the product is no longer a passive investor for kickback purposes. The broader case for physicians starting in venture as investors rather than operators assumes this kind of passive, arm's-length position.

Labs, Imaging Centers, and Other Ancillary Services

This is where the Stark Law most often decides the outcome. A physician who owns part of a lab, imaging center, physical therapy provider, or DME supplier and refers Medicare patients there is squarely within the statute, and outside the publicly traded and rural exceptions there are few ownership exceptions to rely on. Many physicians who hold these interests simply do not refer to the entity, but that has to be true in practice, not just on paper. Kickback analysis runs alongside, using the small-entity 60-40 tests.

Medical Device and Supply Companies

When a physician invests in a company whose products they use or choose, the kickback statute is the main concern. OIG's 2013 Special Fraud Alert described physician-owned distributorships of implantable devices as "inherently suspect," warning that returns tied to a physician-owner's own device use can induce both unnecessary procedures and less appropriate device choices. Separately, the Open Payments program requires drug and device manufacturers and group purchasing organizations to report physician ownership and investment interests to CMS each year under 42 CFR § 403.906, with exceptions for certain publicly traded securities and mutual fund shares. A physician-investor in a private device company should expect that interest to become public.

Advisory Roles With Equity

Advisory shares, consulting fees, and board compensation are compensation arrangements rather than pure investments, and they draw scrutiny when the advisor is also a source of business. The personal services safe harbor and Stark compensation exceptions turn on fair market value, a written agreement, and pay that does not vary with referrals. Physicians who advise companies through structured channels, such as a domain-expert network that evaluates deals rather than buying from them, keep these roles easier to separate.

Red Flags in a Healthcare Investment Offer

OIG's guidance on joint ventures and physician-owned entities points to a recurring set of warning signs. Any one of them is a reason to slow down and involve counsel:

• Investors are selected because they are in a position to refer patients or use the company's products.
• The size of a physician's allocation tracks their expected referral or ordering volume.
• Investors who stop referring, retire, or move are required to divest.
• Returns are out of proportion to the capital invested, or the capital required is nominal.
• The company or its promoters offer loans or guarantees to fund the investor's purchase.
• Referral volume by investor is tracked, reported, or discussed with investors.
• Most of the company's revenue would come from its own investors' patients.
• Physicians are encouraged, explicitly or implicitly, to steer business to the entity.

Questions to Ask Before You Invest

A short, consistent set of questions catches most problems early:

1. Does the company furnish designated health services, or bill Medicare, Medicaid, or another federal program, now or under its planned business model?
2. Will I be in a position to refer patients to, order from, prescribe, or use the products of this company?
3. Are my investment terms identical to those offered to investors who cannot generate business for the company?
4. Is my return strictly proportional to my capital, with no link to referrals or usage?
5. Am I investing directly or through an SPV or fund, and has the indirect ownership been analyzed?
6. Does any part of the arrangement depend on an exception or safe harbor, and has counsel confirmed every element is met?
7. Will my interest be reportable through Open Payments, and am I comfortable with that disclosure?
8. Are there state self-referral or anti-kickback laws that apply even to commercially insured patients?

Regulatory risk belongs in the same diligence file as the market and the team. In The LSM Group's process, each deal is reviewed by a domain expert whose Signal Report addresses regulatory risk alongside technical validation and competitive positioning. That review is investment diligence, not legal advice, and it complements, rather than replaces, a physician's own counsel.

State Laws and Other Federal Rules

The federal statutes are the floor. Many states have their own self-referral and anti-kickback laws, and some apply regardless of payer, which means an arrangement involving only commercially insured patients may still be restricted. The Eliminating Kickbacks in Recovery Act of 2018 (18 U.S.C. § 220) also extends kickback-style prohibitions to all payers for laboratories, recovery homes, and clinical treatment facilities, which matters for anyone considering a diagnostics or lab investment. Physicians licensed in more than one state should expect the analysis to differ by jurisdiction.

Next Steps

The Stark Law and the Anti-Kickback Statute do not prevent physicians from investing in healthcare. They shape how physicians invest: through structures with clear exceptions, at arm's length from their own clinical decisions, and with documentation that will hold up years later. Physicians who build that discipline into every deal can invest in the sectors they understand best without putting their practice at risk.

The LSM Group's investment syndicate brings accredited physician investors domain-expert-vetted opportunities in healthcare, applied AI, and life sciences, with regulatory risk reviewed as part of every Signal Report. For the legal side of any arrangement, the firm's vetted partner network includes experienced healthcare legal counsel. To learn more about joining the syndicate, contact the team at hello@thelsmgroup.com.